ES417796A1 - Procedimiento para la obtencion de derivados de morfolina. - Google Patents

Procedimiento para la obtencion de derivados de morfolina.

Info

Publication number
ES417796A1
ES417796A1 ES417796A ES417796A ES417796A1 ES 417796 A1 ES417796 A1 ES 417796A1 ES 417796 A ES417796 A ES 417796A ES 417796 A ES417796 A ES 417796A ES 417796 A1 ES417796 A1 ES 417796A1
Authority
ES
Spain
Prior art keywords
derivatives
procedure
obtaining
morpholin
methylmorpholine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES417796A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES417796A1 publication Critical patent/ES417796A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ES417796A 1972-08-11 1973-08-11 Procedimiento para la obtencion de derivados de morfolina. Expired ES417796A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3755072A GB1382526A (en) 1972-08-11 1972-08-11 Morpholine derivatives

Publications (1)

Publication Number Publication Date
ES417796A1 true ES417796A1 (es) 1976-02-16

Family

ID=10397311

Family Applications (1)

Application Number Title Priority Date Filing Date
ES417796A Expired ES417796A1 (es) 1972-08-11 1973-08-11 Procedimiento para la obtencion de derivados de morfolina.

Country Status (22)

Country Link
US (2) US3974156A (OSRAM)
JP (2) JPS572710B2 (OSRAM)
AT (8) AT328460B (OSRAM)
AU (2) AU468101B2 (OSRAM)
BE (2) BE803283A (OSRAM)
CH (4) CH594642A5 (OSRAM)
CS (4) CS182790B2 (OSRAM)
DD (2) DD108299A5 (OSRAM)
DE (2) DE2340874A1 (OSRAM)
DK (1) DK135505B (OSRAM)
ES (1) ES417796A1 (OSRAM)
FR (2) FR2195448B1 (OSRAM)
GB (1) GB1382526A (OSRAM)
HU (2) HU166870B (OSRAM)
IE (1) IE37928B1 (OSRAM)
IL (2) IL42841A (OSRAM)
IN (1) IN137769B (OSRAM)
NL (2) NL7311068A (OSRAM)
PL (4) PL90322B1 (OSRAM)
SE (1) SE385889B (OSRAM)
SU (7) SU537627A3 (OSRAM)
ZA (2) ZA735007B (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1064927A (en) * 1975-01-29 1979-10-23 Yuji Kawashima Process of producing 2-(indenyloxymethyl) morpholine derivatives
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB2184438B (en) * 1985-12-19 1990-10-03 Ici Plc Heterocyclic compounds
GB8827152D0 (en) * 1988-11-21 1988-12-29 Wellcome Found Anti-atherosclerotic diaryl compounds
US5290814A (en) * 1988-11-21 1994-03-01 Burroughs Wellcome Co. Anti-atherosclerotic diaryl compounds
EP0507488A1 (en) * 1991-03-27 1992-10-07 Merck & Co. Inc. Inhibitors of HIV-1 reverse transcriptase
AU3364493A (en) * 1992-01-28 1993-09-01 Smithkline Beecham Plc Compounds as calcium channel antagonists
DE69732359T2 (de) 1996-08-23 2005-06-23 Neurosearch A/S Disubstituierte morpholin-, oxazepin- oder thiazepinderivate, deren herstellung und verwendung als dopamin-d4-rezeptorantagonisten
EP1187810A2 (en) * 1999-05-25 2002-03-20 Sepracor, Inc. Heterocyclic analgesic compounds and their use
US6635661B2 (en) 2000-05-25 2003-10-21 Sepracor Inc. Heterocyclic analgesic compounds and methods of use thereof
US6677332B1 (en) 1999-05-25 2004-01-13 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US7361666B2 (en) 1999-05-25 2008-04-22 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
AU2001216218A1 (en) * 2000-05-25 2001-12-11 Sepracor, Inc. Heterocyclic analgesic compounds and method of use thereof
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
CA2422055A1 (en) 2000-09-11 2002-03-21 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
WO2006001326A1 (ja) * 2004-06-24 2006-01-05 Sankyo Company, Limited Ｎ－カルボニル飽和複素環類の製造方法及びその合成中間体
TWI452044B (zh) * 2007-06-15 2014-09-11 Mitsubishi Tanabe Pharma Corp 嗎啉衍生物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH386443A (de) * 1959-12-16 1965-01-15 Geigy Ag J R Verfahren zur Herstellung von neuen tetrasubstituierten Alkylendiaminen
GB1138405A (en) * 1966-12-28 1969-01-01 Ici Ltd Morpholine derivatives

Also Published As

Publication number Publication date
DE2340874A1 (de) 1974-02-21
SU508201A3 (ru) 1976-03-25
CS182798B2 (en) 1978-05-31
ATA701773A (de) 1975-05-15
AU468101B2 (en) 1975-12-18
SU503521A3 (ru) 1976-02-15
DD108299A5 (OSRAM) 1974-09-12
DK135505C (OSRAM) 1977-10-17
AT327931B (de) 1976-02-25
IE37928B1 (en) 1977-11-09
DD107931A5 (OSRAM) 1974-08-20
ATA975074A (de) 1975-05-15
AT326675B (de) 1975-12-29
AU5848573A (en) 1975-01-30
JPS49124079A (OSRAM) 1974-11-27
GB1382526A (en) 1975-02-05
SU508200A3 (ru) 1976-03-25
ZA735007B (en) 1974-06-26
AU5849173A (en) 1975-01-30
HU167000B (OSRAM) 1975-07-28
NL7311068A (OSRAM) 1974-02-13
SU508199A3 (ru) 1976-03-25
CH594644A5 (OSRAM) 1978-01-13
AT327932B (de) 1976-02-25
AT327930B (de) 1976-02-25
JPS5046675A (OSRAM) 1975-04-25
FR2195454A1 (OSRAM) 1974-03-08
SU521844A3 (ru) 1976-07-15
ATA974874A (de) 1975-05-15
IL42841A0 (en) 1973-10-25
SE385889B (sv) 1976-07-26
FR2195448A1 (OSRAM) 1974-03-08
AT328460B (de) 1976-03-25
US3974156A (en) 1976-08-10
CS183681B2 (en) 1978-07-31
SU537627A3 (ru) 1976-11-30
PL90322B1 (OSRAM) 1977-01-31
US3974158A (en) 1976-08-10
BE803283A (fr) 1974-02-06
PL95166B1 (OSRAM) 1977-09-30
CH594645A5 (OSRAM) 1978-01-13
BE803284A (fr) 1974-02-06
ATA925074A (de) 1975-04-15
CH594646A5 (OSRAM) 1978-01-13
DK135505B (da) 1977-05-09
AU471402B2 (en) 1976-04-29
NL7311069A (OSRAM) 1974-02-13
FR2195454B1 (OSRAM) 1977-02-25
CS182799B2 (en) 1978-05-31
ZA735008B (en) 1974-06-26
CH594642A5 (OSRAM) 1978-01-13
IN137769B (OSRAM) 1975-09-13
JPS572710B2 (OSRAM) 1982-01-18
CS182790B2 (en) 1978-05-31
IL42842A0 (en) 1973-10-25
AT327929B (de) 1976-02-25
DE2340873A1 (de) 1974-02-28
IE37928L (en) 1974-02-11
PL91729B1 (OSRAM) 1977-03-31
ATA701673A (de) 1975-06-15
ATA924974A (de) 1975-03-15
AT327210B (de) 1976-01-26
ATA974974A (de) 1975-05-15
PL91728B1 (OSRAM) 1977-03-31
IL42841A (en) 1976-04-30
FR2195448B1 (OSRAM) 1977-02-25
HU166870B (OSRAM) 1975-06-28
SU509231A3 (ru) 1976-03-30

Similar Documents

Publication Publication Date Title
ES417796A1 (es) Procedimiento para la obtencion de derivados de morfolina.
AR213930A1 (es) Procedimiento para la fabricacion de nuevos derivados de 1-ariloxi-3-amidoalquilamino-2-propanol
ES420688A1 (es) Procedimiento para la preparacion de acilanilidas sustitui-das.
AR208171A1 (es) Procedimiento para la obtencion de nuevos derivados del acido cef-3-em-4-carboxilico
IT1001770B (it) Procedimento per la produzione di glicoli vicinali
FI54312C (fi) Foerfarande foer framstaellning av tieno-(2,3-d)pyrimidinderivat med avsoendring av urinsyra i urin utoekande
ES443514A1 (es) Procedimiento para la obtencion de compuestos de acil-hi- drazona.
AR207951A1 (es) Procedimiento para la produccion de nuevos derivados de n-(3-alquilcarbonilamino-2,4,6-triyodobenzoil)-aminoacidos
AR196775A1 (es) Procedimiento para la preparacion de derivados de 1-(3-(5,6,7,8-tetrahidronaft-1-ii-oxi)-propil)- piperazina
AR200500A1 (es) Procedimiento para la obtencion de nuevos derivados de diazapina
AR200869A1 (es) Procedimiento para la obtencion de nuevos derivados del 1-fenoxi-3-amino-propan-2-ol
AR198869A1 (es) Procedimiento para la produccion de nuevos 1-etil-imidazoles
AR205610A1 (es) Procedimiento para la obtencion de nuevos derivados del acido penam-3-carboxilico
ES363965A1 (es) Procedimiento para la obtencion de derivados de piperazina.
AR208184A1 (es) Procedimiento para la fabricacion de derivados de 2-(aminocarbonil-aza-alcanamido)-benzofenoma
ES448056A1 (es) Procedimiento para la preparacion de derivados de morfolina.
AR196912A1 (es) Procedimiento para la produccion de un inhibidor de amilasa
AR196759A1 (es) Procedimiento para la produccion de compuestos, de quinazolina 2,4-diamino- 6 - substitudos (05,6-disubstituidos)
ES380883A1 (es) Procedimiento para la obtencion de derivados de la ergopep-tina.
ES431287A1 (es) Procedimiento para preparar derivados de acido tricloroace-tamido-7 desacetoxi-3 cefalosporanico.
ES389788A1 (es) Procedimiento para la preparacion de derivados fenacinicos.
SE400767B (sv) Forfarande for framstellning av arylpiperazin-derivat av adenin
AR211379Q (es) Procedimiento para preparar derivados de imidazolidin -4- onas -1, 3- disustituidas
ES389789A1 (es) Procedimiento para la preparacion de derivados de fenacina.
AR211510A1 (es) Metodo para producir nuevos derivados de 2,3-dihidro-9-hidroxi-p-dioxino(2,3)-g-quinolina